共 112 条
[1]
Mottet N(2021)EAU-EANM-ESTRO-ESUR-SIOG Guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent Eur Urol 79 243-262
[2]
van den Bergh RCN(2018)Management of biochemical recurrence after primary curative treatment for prostate cancer: a review Urol Int 100 251-262
[3]
Briers E(2006)Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 965-974
[4]
Artibani W(2021)Advanced prostate cancer: AUA/ASTRO/SUO guideline PART I J Urol 205 14-21
[5]
Porcaro AB(2021)Salvage therapy for prostate cancer after radical prostatectomy Nat Rev Urol 18 643-668
[6]
De Marco V(2019)Salvage local treatments after focal therapy for prostate cancer Eur Urol Oncol 2 526-538
[7]
Cerruto MA(2021)EAU-EANM-ESTRO-ESUR-SIOG Guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer Eur Urol 79 263-282
[8]
Siracusano S(2014)Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how? Cancer Radiother 18 524-534
[9]
Roach M(2019)A systematic review on the role of imaging in early recurrent prostate cancer Eur Urol Oncol 2 47-76
[10]
Hanks G(2020)Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 31 1119-1134